An interventional study of Intervention in Alcohol Abuse, Alcohol Drinking and Alcohol Use Disorder, sponsored by Ilona Myllyniemi. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-17.
Sponsored by Ilona Myllyniemi · Not applicable, Interventional, and Prevention
The study aims to investigate the effects that mood tracking may have on the alcohol consumption of adults who consume more than 20 UK units of alcohol per week, classifying as high-risk drinkers. The intervention group will track their mood on a daily basis with a visual analogue scale, while the control group will report their daily time spent online. The hypothesis, based on a series of prior pilot studies on alcohol tracking methods, is that mood tracking can reduce alcohol consumption in high-risk drinkers and therefore be a suitable addition to interventions related to decreasing alcohol consumption in heavy drinkers. The study will be conducted online through the Prolific platform.
Participants will be recruited through Prolific. All participants will complete a series of demographic and psychometric questionnaires before beginning the study. Participants will also complete some of the psychometric questionnaires (RCQ, GAD-7, PHQ-9) at the end of the study to track any potential changes. Participants will be pre-screened for their motivation using a modified MTSS (Motivation to Stop Smoking) scale. Participants will also be asked to report their primary source of motivation regarding wanting to quit or reduce drinking, in addition to reporting their main goal regarding alcohol, where the options will be wanting to quit, wanting to reduce drinking, wanting to be more in control of their drinking, and not wanting to quit, reduce, or be more in control of drinking. All participants will also report their alcohol consumption using a timeline followback task with the ability to view both a calendar and a reference image of UK alcohol units. They'll report their alcohol consumption from the week before the study and complete two TLFBs during the study.
Intervention group participants complete daily visual analogue scales of their mood. Control group participants complete daily reports of how many hours they spent online the previous day.
1,674 studies on the registry are indexed under Alcoholism; 331 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 88 across 1,428 interventional studies indexed under Alcoholism.
Browse Alcoholism studies →This is the only study on the registry with Ilona Myllyniemi as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants complete daily mood tracking and weekly timeline followbacks of alcohol use
Behavioral: Intervention
Participants complete daily logs of time spent online and weekly timeline followbacks of alcohol use
Daily mood tracking tasks
Also known as: Alcohol tracking, Mood tracking, Emotional monitoring, EMA
TLFB
Timeline followbacks completed of consumed alcohol units reflecting alcohol units (UK) of alcohol consumed before the study and throughout the study
Time frame: 3 weeks
GAD-7
Comparison of potential changes in GAD-7 score before and after study
Time frame: 3 weeks
PHQ-9
Comparison of potential changes in PHQ-9 score before and after study
Time frame: 3 weeks
RCQ
Comparison of potential changes in Readiness to Change score and Stage of Change destination before and after study
Time frame: 3 weeks
No study locations are listed for this record.
Plan to share: No — Study protocol, statistical analysis plan, informed consent form will be shared
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.